Bioelectric activity of pelvic floor muscles Not Applicable
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 19 - 29 years 2. Nulliparous 3. Women who have already had intercourse 4. Women without pelvic floor dysfunction
Exclusion criteria
Exclusion criteria: 1. Women before 19 and after 29 years of age 2. Women who gave birth 3. Virgins 4. Pelvic floor dysfunction 5. Sensory deficits 6. Pacemakers and other electronic implants 7. Metal implants 8. Psychiatric disorders 9. Cancer 10. Infections 11. Fever 12. Acute inflammation 13. Hypersensitivity to electricity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bioelectrical activity of pelvic floor muscle measured using an endovaginal electrode, an EMG apparatus and integrated computer software. An assessment of the bioelectrical activity of pelvic floor muscle using the Glazer protocol. The measurements will be performed before the therapy, after the therapy, i.e. 8 weeks later and 4 and 12 weeks after the end of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of the bioelectric activity of the pelvic floor muscles using the glazer protocol: 1. One 60-second rest (pre-baseline) - the women were instructed to feel the pelvic floor in a resting position. 2. Five 2-second phasic (flick) contractions with a 2-second rest in-between - the women were instructed to contract the PFM as quickly as possible, and then quickly and fully relax the PFM immediately after contraction. 3. Five 10-second tonic contractions with a 10-second rest in-between - the women were instructed to contract the PFM as strongly as possible, maintain the contraction for 10?seconds, and then fully relax the PFM after contraction, remaining relaxed for 10?seconds. 4. One 60-second endurance contraction - the women were instructed to contract the PFM at such a level as to hold it for 60? seconds. 5. One 60-second rest (post-baseline) - the women were instructed to feel the pelvic floor in a resting position. The measurements will be performed before the therapy, after the therapy and 1 and 3 months after the end of the intervention. | — |
Countries
Poland